Catherine Tomaro-Duchesneau

Author

McGill University ORCID

Also Known As

C. Tomaro-Duchesneau, Catherine Tomaro- Duchesneau, Catherine Tomaro-Duchesneau

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

McGill University Baylor College of Medicine Cell Technology (China)Université de Montréal

About

Catherine Tomaro-Duchesneau is an author at McGill University specializing in medicine, microbiology, and probiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	8	928
2	Health Sciences	5	5	330
3	Engineering	4	4	306
4	Public Health	3	4	600
5	Biochemistry	3	3	224

Catherine Tomaro-Duchesneau

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Gut microbiota: next frontier in understanding human health and development of biotherapeutics Satya Prakash, Laetitia Rodes, Michael Coussa-Charley, Biologics DysbiosisHost-microbe InteractionsGut MicrobiotaHuman Gut MicrobiotaHuman Microbial Flora	2011	254
Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases Meenakshi Malhotra, Catherine Tomaro-Duchesneau, Satya Prakash Biomaterials NanoparticlesNanomedicineNeurodegenerative DiseasesEngineeringTherapeutic Nanomaterials	2012	189
Cholesterol Assimilation by<i>Lactobacillus</i>Probiotic Bacteria: An<i>In Vitro</i>Investigation Catherine Tomaro-Duchesneau, Mitchell Jones, Divya Shah, BioMed Research International ProbioticDysbiosisExcess CholesterolBiochemistryHealth Sciences	2014	145
A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis Meenakshi Malhotra, Catherine Tomaro-Duchesneau, Shyamali Saha, International Journal of Nanomedicine	2011	105
Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA Satya Prakash, Catherine Tomaro-Duchesneau, Shyamali Saha, International Journal of Nanomedicine	2013	102
Human Intestinal Enteroids With Inducible Neurogenin-3 Expression as a Novel Model of Gut Hormone Secretion Alexandra L. Chang‐Graham, Heather A. Danhof, Melinda A. Engevik, Cellular and Molecular Gastroenterology and Hepatology	2019	82
Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats Catherine Tomaro-Duchesneau, Shyamali Saha, Meenakshi Malhotra, Applied Microbiology and Biotechnology NutritionMetabolic SyndromeEnergy MetabolismVivo AnalysisMetabolic Disorder	2013	75
The gut microbiome, probiotics, bile acids axis, and human health Mitchell Jones, Catherine Tomaro-Duchesneau, Satya Prakash Trends in Microbiology NutritionProbioticMicrobiota FunctionBile Acids AxisDysbiosis	2014	61
Probiotic Ferulic Acid Esterase Active Lactobacillus fermentum NCIMB 5221 APA Microcapsules for Oral Delivery: Preparation and in Vitro Characterization Catherine Tomaro-Duchesneau, Shyamali Saha, Meenakshi Malhotra, Pharmaceuticals Vitro CharacterizationProbioticEngineeringApa MicrocapsuleMedicine	2012	60
Oral Probiotic Microcapsule Formulation Ameliorates Non-Alcoholic Fatty Liver Disease in Bio F1B Golden Syrian Hamsters Jasmine Bhathena, Christopher Martoni, Arun Kulamarva, PLoS ONE NutritionPathologyFatty Liver DiseaseMetabolic SyndromeProbiotic	2013	48

Page 1